Saint Louis University researchers study oral drug for multiple sclerosis

Thursday, April 5, 2012 | 9:06 a.m. CDT; updated 9:15 a.m. CDT, Thursday, April 5, 2012

ST. LOUIS — Researchers at Saint Louis University are part of a study looking at an oral drug aimed at helping people with multiple sclerosis.

MS affects about 400,000 people in the U.S., including about 10,000 diagnosed each year. The body's immune system attacks the protective coating surrounding the nerves within the central nervous system, along with the nerve fibers themselves. Symptoms generally include fatigue, pain, muscle weakness and impaired mobility, balance, cognition and vision.

Most multiple sclerosis treatments are injected. Saint Louis University researcher Florian Thomas said a tablet may make it easier for patients to avoid missing doses.

The university is seeking study participants between the ages of 18 and 56. Some will get the investigational drug, others a placebo.


Like what you see here? Become a member.

Show Me the Errors (What's this?)

Report corrections or additions here. Leave comments below here.

You must be logged in to participate in the Show Me the Errors contest.


Leave a comment

Speak up and join the conversation! Make sure to follow the guidelines outlined below and register with our site. You must be logged in to comment. (Our full comment policy is here.)

  • Don't use obscene, profane or vulgar language.
  • Don't use language that makes personal attacks on fellow commenters or discriminates based on race, religion, gender or ethnicity.
  • Use your real first and last name when registering on the website. It will be published with every comment. (Read why we ask for that here.)
  • Don’t solicit or promote businesses.

We are not able to monitor every comment that comes through. If you see something objectionable, please click the "Report comment" link.

You must be logged in to comment.

Forget your password?

Don't have an account? Register here.